10-Desacetyl paclitaxel
CAS: 78432-77-6
Ref. 3D-FD21126
5mg | 136,00 € | ||
10mg | 192,00 € | ||
25mg | 325,00 € | ||
50mg | 406,00 € | ||
100mg | 542,00 € |
Información del producto
- 10-Deacetylpaclitaxel10-Deacetyltaxol10-Desacetyltaxol
- (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
- 10-Deacetylpaclitaxel
- 10-Deacetyltaxol
- 10-Deacetyltaxol A
- 10-Desacetylpaclitaxel
- 10-Desacetyltaxol
- 10-O-Deacetyltaxol
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- 7-Epi-10-deacetyl paclitaxel
- Ver más sinónimos
- Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-
- b-(Benzoylamino)-a-hydroxy-benzenepropanoic acid [2aR-[2aa,4b,4ab,6b,9a(aR*,bS*),11a,12a,12aa,12ba]]-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester
10-Desacetyl paclitaxel is a form of paclitaxel that has been modified chemically. It is soluble in water and can be injected intravenously. 10-Desacetyl paclitaxel is used to treat inflammatory diseases, such as rheumatoid arthritis and psoriasis. This drug binds to the hydroxyl groups on the surface of the bacterial cell wall and prevents the formation of covalent linkages with polysaccharides, which leads to its increased patency in bacterial cells. 10-Desacetyl paclitaxel has also been shown to inhibit the activity of certain enzymes that are involved in synthesis of DNA, RNA, and proteins. This inhibition results in cell death by apoptosis or necrosis. The increase in viability after treatment with 10-desacetyl paclitaxel was observed for both gram-positive bacteria (e.g., Bacillus subtilis) and gram-negative bacteria (e.g., Escher
Propiedades químicas
Consulta técnica sobre: 3D-FD21126 10-Desacetyl paclitaxel
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.